Synlett 2016; 27(09): 1359-1362
DOI: 10.1055/s-0035-1561352
letter
© Georg Thieme Verlag Stuttgart · New York

A Novel Copper-Catalyzed Preparation of Pyrido[1,2-a]pyrimidine Derivatives

Mohammad Mahdavi
a   Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran
,
Roxana Fazli Estabragh
a   Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran
,
Setareh Moghimi
a   Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran
,
Mohammad Hosein Sayahi
b   Department of Chemistry, Payame Noor University (PNU), P.O. Box 19395-3697, Tehran, Iran   Email: aforoumadi@yahoo.com
,
Abbas Shafiee
a   Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran
,
Alireza Foroumadi*
a   Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran
b   Department of Chemistry, Payame Noor University (PNU), P.O. Box 19395-3697, Tehran, Iran   Email: aforoumadi@yahoo.com
› Author Affiliations
Further Information

Publication History

Received: 17 August 2015

Accepted after revision: 12 January 2016

Publication Date:
04 March 2016 (online)


Abstract

A copper-catalyzed reaction of 2-amino-1-(prop-2-yn-1-yl)pyridinium bromide derivatives and aromatic sulfonyl azides has been demonstrated under mild condition.

 
  • References and Notes

    • 1a Stevens CL, Nagarajart IC, Hoskell TH. J. Org. Chem. 1962; 27: 2991
    • 1b Schwan TJ, Tieekelmann H, Holland JF, Bryant B. J. Med. Chem. 1965; 8: 750
    • 1c Takia T, Muraoka Y, Nakatani T, Fujii A, Urnezaweg Y, Naganawa H, Umezava H. J. Antibiot. 1978; 31: 01
    • 1d Onuma S, Nawata Y, Saito Y. Bull. Chem. Soc. 1966; 39: 1901
  • 2 Peng L, Gao X, Duan L, Ren X, Wu D, Ding K. J. Med. Chem. 2011; 54: 7729
  • 3 Mane UR, Mohanakrishnan D, Sahal D, Murumkar PR, Giridhar R, Yadav MR. Eur. J. Med. Chem. 2014; 79: 422
  • 4 La Motta C, Sartini S, Mugnaini L, Simorini F, Taliani S, Salerno S, Marini AM, Da Settimo F, Lavecchia A, Novellino E, Cantore M, Failli P, Ciuffi M. J. Med. Chem. 2007; 50: 4917
  • 5 Kozlovskaya MM, Inozemtsev AN, Nikitin SV, Gochmuradov AG, Yakushev RA, Chabak-Gorbach R. Bull. Exp. Biol. Med. 1995; 119: 291
  • 6 Wu Y.-J, He H, Hu S, Huang Y, Scola PM, Grant-Young K, Bertekap RL, Wu D, Gao Q, Li Y, Klakouski C, Westphal RS. J. Med. Chem. 2003; 46: 4834
  • 7 Nakayama K, Kawato H, Watanabe J, Ohtsuka M, Yoshida K.-I, Yokomizo Y, Sakamoto A, Kuru N, Ohta T, Hoshino K, Yoshida K, Ishida H, Cho A, Palme MH, Zhang JZ, Lee VJ, Watkins WJ. Bioorg. Med. Chem. Lett. 2004; 14: 475
  • 8 Roma G, Di Braccio MB, Albi A, Mazzei M, Ermili A. J. Heterocycl. Chem. 1987; 24: 329
  • 9 Dorokhov VA, Baranin SV, Dib A, Bogdanov VS, Yakovlev IP, Stashina GA, Zhulin VM. Chem. Abstr. 1991; 114: 101911
  • 10 Pryadeina MV, Burgart YV, Kodess MI, Saloutin VI. Russ. Chem. Bull. 2005; 54: 2841
  • 11 Rostovtsev VV, Green LG, Fokin VV, Sharpless KB. Angew. Chem. Int. Ed. 2002; 41: 2596
  • 12 Whiting M, Fokin VV. Angew. Chem. Int. Ed. 2006; 45: 3157
  • 13 Staudinger H, Hauser E. Helv. Chim. Acta 1921; 4: 887

    • For reactions between ketenimines and heteroatomic nucleo­philes, see:
    • 14a Xu H.-D, Jia Z.-H, Xu K, Han M, Jiang S.-N, Cao J, Wang J.-C, Shen M.-H. Angew. Chem. Int. Ed. 2014; 53: 9284
    • 14b Yoo EJ, Bae I, Chao SH, Han H, Chang S. Org. Lett. 2006; 8: 1347
    • 14c Bae I, Han H, Chang S. J. Am. Chem. Soc. 2005; 127: 2038
    • 14d Shaabani A, Sarvary A, Ghasemi S, Rezayan R, Ghaderi R, Ng SW. Green Chem. 2011; 13: 582
    • 14e Chao SH, Yoo EJ, Bae I, Chang S. J. Am. Chem. Soc. 2005; 127: 16046
    • 14f Larksarp C, Sellier O, Alper H. J. Org. Chem. 2001; 66: 3502

      For reactions between ketenimines and carbon nucleophiles, see:
    • 15a Wang J, Wang JJ, Zhu YX, Lu P, Wang YG. Chem. Commun. 2011; 3275
    • 15b Shang YJ, Ju K, He XW, Hu JS, Yu SY, Zhang M, Liao KS, Wang LF, Zhang P. J. Org. Chem. 2010; 75: 5743
    • 15c Shang Y, Ju K, He X, Hu J, Yu S, Zhang M, Liao K, Wang L, Zhang P. J. Org. Chem. 2010; 75: 5743
    • 15d Chao SH, Chan S. Angew. Chem. Int. Ed. 2008; 47: 2836
  • 16 Lu P, Wang Y.-G. Chem. Soc. Rev. 2012; 41: 5687 ; and references cited therein
    • 17a Yoo EJ, Chang S. Org. Lett. 2008; 10: 1163
    • 17b Wang J, Wang J, Lu P, Wang Y. J. Org. Chem. 2013; 78: 8816
    • 17c Murugavel G, Punniyamurthy T. Org. Lett. 2013; 15: 3828
    • 17d Murugavel G, Punniyamurthy T. J. Org. Chem. 2015; 80: 6291
    • 17e Chen JL, Namirembe S, Lauchert LT, Tsougranis GH, Isaacs AK. Tetrahedron Lett. 2015; 56: 4105
    • 18a Rasouli MA, Mahdavi M, Firoozpour L, Shafiee A, Foroumadi A. Tetrahedron 2014; 70: 3931
    • 18b Mahdavi M, Najafi R, Saeedi M, Alipour E, Shafiee A, Foroumadi A. Helv. Chim. Acta 2013; 96: 419
    • 19a Shafii B, Saeedi M, Mahdavi M, Foroumadi A, Shafiee A. Synth. Commun. 2014; 44: 215
    • 19b Farzipour S, Saeedi M, Mahdavi M, Yavari H, Mirzahekmati M, Ghaemi N, Foroumadi A, Shafiee A. Synth. Commun. 2014; 44: 481
    • 19c Mahdavi M, Asadi M, Saeedi M, Tehrani MH, Mirfazli SS, Shafiee A, Foroumadi A. Synth. Commun. 2013; 43: 2936
    • 19d Ebrahimi SM, Mahdavi M, Emami S, Saeedi M, Asadi M, Firoozpour L, Khoobi M, Divsalar K, Shafiee A, Foroumadi A. Synth. Commun. 2014; 44: 665
    • 19e Asadi M, Ebrahimi M, Mahdavi M, Saeedi M, Ranjbar PR, Yazdani F, Shafiee A, Foroumadi A. Synth. Commun. 2013; 43: 2385
    • 20a Xing Y, Sheng G, Wang J, Lu P, Wang Y. Org. Lett. 2014; 16: 1244
    • 20b Waser J, Gasper B, Nambu H, Carreira EM. J. Am. Chem. Soc. 2006; 128: 11693
  • 21 General Procedure for the Preparation of Pyrido[1,2-a]pyrimidines 9a–i: To the stirred solution of alkyne (1 mmol), azide (1 mmol), CuI (10 mol%) in DMF (3 mL), Et3N (1 mmol) was added under N2. The mixture was stirred at r.t. for 12 h. After dilution with CH2Cl2, the aqueous solution of NH4Cl was added and the stirring was continued for 30 min. The aqueous layer was extracted with CH2Cl2 and dried over Na2SO4. The solvent was removed under reduced pressure and the residue was purified by column chromatography (EtOAc–EtOH, 10:1) to afford the pure product. N-(2H-Pyrido[1,2-a]pyrimidin-2-ylidene)benzenesulfonamide (9a): yield: 0.23 g (79%); pale yellow powder; mp 254–256 °C. IR (KBr): 3283, 1644, 1463, 1321, 1130, 763, 692 cm–1. 1H NMR (500 MHz, DMSO-d 6): δ = 6.94 (d, J = 7.5 Hz, 1 H), 7.25 (dt, J = 6.8, 1.0 Hz, 1 H), 7.40 (d, J = 9.0 Hz, 1 H), 7.45–7.49 (m, 3 H), 7.92–7.95 (m, 3 H), 8.41 (d, J = 6.6 Hz, 1 H), 8.53 (d, J = 7.5 Hz, 1 H). 13C NMR (125 MHz, DMSO-d 6): δ = 114.8, 123.9, 124.3, 127.6, 129.1, 133.7, 135.6, 139.3, 143.8, 148.1, 149.5, 160.9. Anal. Calcd for C14H11N3O2S: C, 58.94; H, 3.89; N, 14.73. Found: C, 58.73; H, 3.75; N, 14.99.